Alemtuzumab scFv fragments and CD52 interaction study through molecular dynamics simulation and binding free energy
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Molecular Graphics and Modelling
- Vol. 107, 107949
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 56 references indexed in Scilit:
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics, 2013
- Lipidbook: A Public Repository for Force-Field Parameters Used in Membrane SimulationsThe Journal of Membrane Biology, 2010
- I-TASSER: a unified platform for automated protein structure and function predictionNature Protocols, 2010
- Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse modelImmunology, 2009
- GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular SimulationJournal of Chemical Theory and Computation, 2008
- Canonical sampling through velocity rescalingThe Journal of Chemical Physics, 2007
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- H++: a server for estimating pKas and adding missing hydrogens to macromoleculesNucleic Acids Research, 2005
- Molecular dynamics simulations of biomoleculesNature Structural & Molecular Biology, 2002
- Molecular dynamics with coupling to an external bathThe Journal of Chemical Physics, 1984